The promising role of tumor-associated macrophages in the treatment of cancer

Drug Resist Updat. 2024 Mar:73:101041. doi: 10.1016/j.drup.2023.101041. Epub 2024 Jan 3.

Abstract

Macrophages are important components of the immune system. Mature macrophages can be recruited to tumor microenvironment that affect tumor cell proliferation, invasion and metastasis, extracellular matrix remodeling, immune suppression, as well as chemotherapy resistance. Classically activated type I macrophages (M1) exhibited marked tumor killing and phagocytosis. Therefore, using macrophages for adoptive cell therapy has attracted attention and become one of the most effective strategies for cancer treatment. Through cytokines and/or chemokines, macrophage can inhibit myeloid cells recruitment, and activate anti-tumor and immune killing functions. Applying macrophages for anti-tumor delivery is one of the most promising approaches for cancer therapy. This review article introduces the role of macrophages in tumor development and drug resistance, and the possible clinical application of targeting macrophages for overcoming drug resistance and enhancing cancer therapeutics, as well as its challenges.

Keywords: Drug resistance; Immunotherapy; M1; M2; Polarization; Tumor-associated macrophages.

Publication types

  • Review

MeSH terms

  • Cytokines
  • Humans
  • Macrophages
  • Neoplasms* / pathology
  • Tumor Microenvironment
  • Tumor-Associated Macrophages*

Substances

  • Cytokines